Related Experiment Videos
[Effect of cepharanthin on radiotherapy induced leukopenia]
Rinsho Hoshasen. Clinical Radiography
|April 1, 1990
Summary
Cepharanthin effectively prevents leukopenia during cancer radiotherapy. This alkaloid showed a higher protective rate against low white blood cell counts compared to S-Adchnon and Hythiol treatments.
Area of Science:
- Oncology
- Pharmacology
Background:
- Leukopenia is a common side effect of radiotherapy in cancer patients.
- Alkaloids, such as Cepharanthin, have shown potential in mitigating treatment-induced toxicities.
Purpose of the Study:
- To evaluate the efficacy of Cepharanthin in preventing radiation-induced leukopenia.
- To compare Cepharanthin with S-Adchnon and Hythiol for leukopenia protection during cancer radiotherapy.
Main Methods:
- A randomized study involving 94 cancer patients undergoing radiotherapy.
- Patients received either Cepharanthin, S-Adchnon, or Hythiol.
- Leukopenia incidence was monitored post-treatment.
Main Results:
- Cepharanthin demonstrated an 81.3% protection rate against leukopenia.
- S-Adchnon showed a 51.6% protection rate, while Hythiol had a 32.3% rate.
- Cepharanthin was significantly more effective in preventing leukopenia.
Conclusions:
- Prophylactic administration of Cepharanthin may be beneficial for cancer patients undergoing radiotherapy.
- Cepharanthin offers a promising strategy to manage radiation-induced leukopenia.
- Further research into Cepharanthin's role in supportive cancer care is warranted.